Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Melatonin-Induced Changes in Cytosolic Calcium Might be Responsible for Apoptosis Induction in Tumour Cells

B. Chovancova, S. Hudecova, L. Lencesova, P. Babula, I. Rezuchova, A. Penesova, M. Grman, R. Moravcik, M. Zeman, O. Krizanova,

. 2017 ; 44 (2) : 763-777. [pub] 20171123

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18010262

BACKGROUND/AIMS: Melatonin is a hormone transferring information about duration of darkness to the organism and is known to modulate several signaling pathways in the cells, e.g. generation of endoplasmic reticulum stress, oxidative status of the cells, etc. Melatonin has been shown to exert antiproliferative and cytotoxic effects on various human cancers. We proposed that this hormone can differently affect tumour cells and healthy cells. METHODS: We compared the effect of 24 h melatonin treatment on calcium transport (by fluorescent probes FLUO-3AM and Rhod-5N), ER stress (determined as changes in the expression of CHOP, XBP1 and fluorescently, using Thioflavin T), ROS formation (by CellROX® Green/Orange Reagent) and apoptosis induction (by Annexin-V-FLUOS/propidiumiodide) in two tumour cell lines - ovarian cancer cell line A2780 and stable cell line DLD1 derived from colorectal carcinoma, with non-tumour endothelial cell line EA.hy926. RESULTS: Melatonin increased apoptosis in both tumour cell lines more than twice, while in EA.hy926 cells the apoptosis was increased only by 30%. As determined by silencing with appropriate siRNAs, both, type 1 sodium/calcium exchanger and type 1 IP3 receptor are involved in the apoptosis induction. Antioxidant properties of melatonin were significantly increased in EA.hy926 cells, while in tumour cell lines this effect was much weaker. CONCLUSION: Taken together, melatonin has different antioxidative effects on tumour cells compared to non-tumour ones; it also differs in the ability to induce apoptosis through the type 1 sodium/calcium exchanger, and type 1 IP3 receptor. Different targeting of calcium transport systems in tumour and normal, non-tumour cells is suggested as a key mechanism how melatonin can exert its anticancer effects. Therefore, it might have a potential as a novel therapeutic implication in cancer treatment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010262
003      
CZ-PrNML
005      
20180417111603.0
007      
ta
008      
180404s2017 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000485290 $2 doi
035    __
$a (PubMed)29169174
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Chovancova, Barbora $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
245    10
$a Melatonin-Induced Changes in Cytosolic Calcium Might be Responsible for Apoptosis Induction in Tumour Cells / $c B. Chovancova, S. Hudecova, L. Lencesova, P. Babula, I. Rezuchova, A. Penesova, M. Grman, R. Moravcik, M. Zeman, O. Krizanova,
520    9_
$a BACKGROUND/AIMS: Melatonin is a hormone transferring information about duration of darkness to the organism and is known to modulate several signaling pathways in the cells, e.g. generation of endoplasmic reticulum stress, oxidative status of the cells, etc. Melatonin has been shown to exert antiproliferative and cytotoxic effects on various human cancers. We proposed that this hormone can differently affect tumour cells and healthy cells. METHODS: We compared the effect of 24 h melatonin treatment on calcium transport (by fluorescent probes FLUO-3AM and Rhod-5N), ER stress (determined as changes in the expression of CHOP, XBP1 and fluorescently, using Thioflavin T), ROS formation (by CellROX® Green/Orange Reagent) and apoptosis induction (by Annexin-V-FLUOS/propidiumiodide) in two tumour cell lines - ovarian cancer cell line A2780 and stable cell line DLD1 derived from colorectal carcinoma, with non-tumour endothelial cell line EA.hy926. RESULTS: Melatonin increased apoptosis in both tumour cell lines more than twice, while in EA.hy926 cells the apoptosis was increased only by 30%. As determined by silencing with appropriate siRNAs, both, type 1 sodium/calcium exchanger and type 1 IP3 receptor are involved in the apoptosis induction. Antioxidant properties of melatonin were significantly increased in EA.hy926 cells, while in tumour cell lines this effect was much weaker. CONCLUSION: Taken together, melatonin has different antioxidative effects on tumour cells compared to non-tumour ones; it also differs in the ability to induce apoptosis through the type 1 sodium/calcium exchanger, and type 1 IP3 receptor. Different targeting of calcium transport systems in tumour and normal, non-tumour cells is suggested as a key mechanism how melatonin can exert its anticancer effects. Therefore, it might have a potential as a novel therapeutic implication in cancer treatment.
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a cytosol $x metabolismus $7 D003600
650    _2
$a stres endoplazmatického retikula $x účinky léků $7 D059865
650    _2
$a lidé $7 D006801
650    _2
$a inositol-1,4,5-trisfosfát - receptory $x antagonisté a inhibitory $x genetika $7 D053496
650    _2
$a melatonin $x toxicita $7 D008550
650    _2
$a fluorescenční mikroskopie $7 D008856
650    _2
$a RNA interference $7 D034622
650    _2
$a malá interferující RNA $x metabolismus $7 D034741
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a pumpa pro výměnu sodíku a vápníku $x antagonisté a inhibitory $x genetika $x metabolismus $7 D019831
650    _2
$a transkripční faktor CHOP $x genetika $x metabolismus $7 D051742
650    _2
$a XBP1 $x genetika $x metabolismus $7 D000071717
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hudecova, Sona $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Lencesova, Lubomira $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Babula, Petr $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Rezuchova, Ingeborg $u Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Penesova, Adela $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Grman, Marian $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Moravcik, Roman $u Department of Animal Physiology and Ethology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia.
700    1_
$a Zeman, Michal $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Krizanova, Olga $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
773    0_
$w MED00173244 $t Cellular physiology and biochemistry $x 1421-9778 $g Roč. 44, č. 2 (2017), s. 763-777
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29169174 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180417111701 $b ABA008
999    __
$a ok $b bmc $g 1287747 $s 1007074
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 44 $c 2 $d 763-777 $e 20171123 $i 1421-9778 $m Cellular physiology and biochemistry $n Cell Physiol Biochem $x MED00173244
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Archiving options